Results 291 to 300 of about 9,724,101 (403)

Identification of a Fusobacterial RNA-binding protein involved in host small RNA-mediated growth inhibition. [PDF]

Int J Oral Sci
Dong PT, Yang M, Hu J, Cen L, Zhou P, Xu D, Xiong P, Li J, He X.   +8 more
europepmc   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Chlorogenic acid reverses growth inhibition by suppressing the hypothalamic COX-2 signaling pathway in broilers under LPS-induced immune stress. [PDF]

Poult Sci
Bai D, Zhen W, Liu K, Xiao X, Tan H, Hu X, Ma X, Xie X, Zhang Y, Guo F, Ito K, Zhang B, Zhang C, Ma Y.   +13 more
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Acute Plasmodium yoelii 17XNL Infection During BCG Vaccination Limits T Cell Responses and Mycobacterial Growth Inhibition. [PDF]

Immunology
Tangie E, Pinpathomrat N, Tanner R, Hsu NJ, Spencer AJ, Jacobs M, Mcshane H, Keeton R.   +7 more
europepmc   +1 more source

A Tumor Growth Inhibition Model for Low-Grade Glioma Treated with Chemotherapy or Radiotherapy

Clinical Cancer Research, 2012
B. Ribba, G. Kaloshi, M. Peyre, D. Ricard, V. Calvez, M. Tod, B. Cajavec-Bernard, A. Idbaih, D. Psimaras, L. Dainese, J. Pallud, S. Cartalat‐Carel, J. Delattre, J. Honnorat, E. Grenier, F. Ducray   +15 more
semanticscholar   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Mycobacterium tuberculosis growth inhibition by peripheral blood mononuclear cells from household contacts is not affected by previous SARS-CoV-2 infection. [PDF]

Gates Open Res
Shaw JA, Petersen C, Hiemstra A, Meiring M, Eribo OA, Otum C, van Rensburg I, Shabangu A, Smith B, Noor F, Walzl G, Urdahl KB, Lewinsohn D, Malherbe ST, du Plessis N.   +14 more
europepmc   +1 more source

Inhibition of prostate cancer growth and metastasis using small interference RNA specific for minichromosome complex maintenance component 7

, 2010
Y-K. Shi, Yanping Yu, George C. Tseng, J-H Luo   +3 more
openalex   +1 more source

Growth Inhibition Screening Result [PDF]

, 2020
openaire   +1 more source